Actively Recruiting
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
Led by University of Luebeck · Updated on 2025-01-03
100
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University of Luebeck
Lead Sponsor
U
University Hopsital Schleswig Holstein Campus Lübeck
Collaborating Sponsor
AI-Summary
What this Trial Is About
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
CONDITIONS
Official Title
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has been treated transaxillary (TAX) with Myval transcatheter aortic valve replacement
- BMI <35 kg/m2
- Ability to give informed consent
You will not qualify if you...
- History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
- Age �318 years
- Patients presenting with pregnancy
- Patients without informed consent
- Expected life expectancy <2 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universität zu Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538
Actively Recruiting
Research Team
I
Ingo Eitel, Prof. Dr.
CONTACT
R
Roza Saraei, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here